Levonest Kit
Product Images NDC 16714-340

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levonest (NDC 16714-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure diagrams of the active ingredients levonorgestrel and ethinyl estradiol, shown with labeled atoms and bonds relevant to each molecule. These structures correspond to the hormone compounds used in the Levonest kit by Northstar Rx LLC.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A boxed warning text panel highlighting the increased risk of serious cardiovascular side effects from oral contraceptive use due to cigarette smoking, particularly marked in women over 35 years of age and those smoking 15 or more cigarettes per day. It advises women using oral contraceptives to avoid smoking.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
A bar chart titled "Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral-Contraceptive Use" showing mortality rates across four age groups (15-24, 25-34, 35-44, 45-). The chart compares ever-users and control groups of oral contraceptives, further divided by smoking status (non-smokers and smokers). Mortality rates increase with age, with highest rates observed in smokers aged 45 and older who are controls.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
A warning text panel advising that cigarette smoking increases the risk of serious adverse effects on the heart and blood vessels from oral contraceptive use. The risk is heightened with age and smoking amount, particularly in women over 35 years. It strongly advises women using oral contraceptives not to smoke.*
FDA Label Image

Image-05 (Image 05)

Image-05 (Image 05)
A boxed warning text stating that cigarette smoking increases the risk of serious adverse effects on the heart and blood vessels from oral-contraceptive use, emphasizing greater risk with age and smoking 15 or more cigarettes daily, particularly in women over 35 years. It advises that women using oral contraceptives should not smoke.*
FDA Label Image

Image-06 (Image 06)

Image-06 (Image 06)
Levonest oral contraceptive kit blister pack label showing a 28-day pill schedule with color-coded tablets: yellow (6), green (5), light brown (10), and white (7). It includes instructions to begin tablets in week 2 and storage conditions. The label indicates a monthly user break exam and is manufactured by Novatest Laboratories Ltd.*
FDA Label Image

Image-07 (Image 07)

Image-07 (Image 07)
An instructional diagram showing how to peel and place a day label on a Levonest oral contraceptive pill kit. The image includes a hand placing a strip labeled with days of the week on the pill pack to indicate the start day for taking the medication. The pill pack is sectioned into weeks with different colored pills.*
FDA Label Image

Image-08 (Image 08)

FDA Label Image

Image-09 (Image 09)

Image-09 (Image 09)
Packaging label for Levonest, a kit containing levonorgestrel and ethinyl estradiol tablets USP in a triphasic regimen. The label lists three strengths of tablets within the kit: 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, and 0.125 mg/0.03 mg. The product is labeled by Northstar Rx LLC and includes a barcode and text specifying package details such as 6 blister packs with 21 tablets each. The design features green typography and a small floral graphic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.